Skip to content Skip to navigation

Antitrust

Covestro Plant

The complaint for this class action alleges that an anticompetitive conspiracy has existed in the US to raise the price of MDIs and TDIs, which are precursor ingredients for foam and related products, since at least January 1, 2016.

Micron DRAM

When a handful of companies control 95% of a market, it is much easier to make anticompetitive arrangements. That has been the situation in the DRAM market, and the complaint for this class action claims that makers of DRAM components did in fact conspire to fix and inflate prices, causing price rises of, on average, more than 300% during the class period.

Three Pieces of Raw Pork

The complaint for this class action details what it alleges is an anticompetitive conspiracy among the principal pork producers and a provider of statistics that has allowed them to raise pork prices since 2009. The complaint claims that the conspiracy violates federal antitrust laws.

Los Angeles Highways

Did companies keep the price of gasoline high in California while the rest of the country was enjoying lower prices? The complaint for this antitrust class action claims that a conspiracy kept the price as much as $1.50 higher than the national average, and that Californians paid $10 billion more for gas than they should have. Among the methods allegedly used, the complaint cites false maintenance shutdowns and the sustaining of shortages by exporting gasoline supplies out of California. 

Illustration of Train Braking System

The complaint for this class action alleges that the anti-competitive agreements between rail companies in this case were aimed not at limiting technology or suppressing new products or keeping prices high. They were aimed at limiting competition for workers and keeping wages down. The complaint claims that on April 3, 2018, the Antitrust Division of the US Department of Justice (DOJ) filed a civil antitrust action and announced a settlement with two of the defendants in this case, Knorr Brake Company and Westinghouse Air Brake Technologies Corporation.

Row of Dental Instruments

The complaint for this securities class action claims that Patterson Companies, Inc., colluded with its two main dental product competitors to keep prices high and maintain profit margins. Among other things, the companies agreed not to do business with Group Purchasing Organizations, which were intended to enable small practices to obtain bulk prices. This antitrust activity, the complaint says, was hidden from investors, in violation of the Securities Exchange Act of 1934, artificially boosting Patterson’s sales figures and stock price until the truth emerged.

O2 Arena in London

“London’s most essential large concert venue” is the O2 Arena, selling fifty percent more tickets in 2016 than any other arena-sized venue in the world. Why, then, has rock star Ozzy Osbourne filed a class action relating to it? Because, the complaint says, Anschutz Entertainment Group, Inc. (AEG) requires that artists who book the O2 as part of a tour also book the Staples Center for the Los Angeles part of their tours, in what the complaint says is an anti-competitive condition that violates antitrust laws.

Panasonic Inductor

The US Department of Justice obtained guilty pleas in a recent antitrust case relating to makers of capacitors. Now comes a similar price-fixing case relating to makers of inductors, another type of electronic component, alleging violations of the Sherman Act. The complaint alleges that the defendants, who control 75% of the global market, colluded to raise inductor prices and keep them high.

Pile of Silicone Wristbands

The complaint for this class action alleges that antitrust price-fixing in the business of selling and customizing the silicone wristbands for our favorite charities, the lanyards from which we hang our IDs and keys, and the pin buttons touting slogans or political candidates. Acording to the complaint, the market for these custom promotional products in US is a $22.9 billion industry. Four of the defendants in this case (two companies and two individuals) have already pleaded guilty in a Department of Justice antitrust case, and this case asks for restitution for the people who have paid higher prices because of the defendants’ behavior.

Hand Holding Remicade Bottle

In 2010, Congress enacted a Biologics Price Competition and Innovation Act to enable biosimilar drugs to receive approval, to spur price competition for drugs. However, the complaint for this class action alleges that when other companies developed competitors for Remicade, Johnson & Johnson (J&J) unfairly blocked their access to the market, with exclusivity contracts and other provisions with insurers, requiring consumers to pay significantly higher prices than they would otherwise have.

Pages